Three Editorial Board Members of Metabolism and Target Organ Damage Named on the List of Clarivate "Highly Cited Researchers 2023"

On November 15, 2023, Clarivate Analytics announced its "Highly Cited Researchers 2023" list. Each researcher on this list has authored multiple Highly Cited Papers™ that rank in the top 1% by citations for their field(s) and publication year in the Web of Science™ over the past decade. In 2023, a total of 7,125 highly cited researchers were named. The Editorial Office of Metabolism and Target Organ Damage (M&TOD) is delighted to announce that three renowned researchers - Editor-in-Chief Prof. Amedeo Lonardo, and Honorary Editors-in-Chief, Prof. Giovanni Targher and Prof. Christopher D. Byrne, have been included in this distinguished list.

The Editorial Office of M&TOD extends heartfelt congratulations to these three esteemed researchers for their well-deserved recognition as "Highly Cited Researchers 2023" by Clarivate!

Prof. Amedeo Lonardo      
Editor-in-Chief of M&TOD      
Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.      
Amedeo Lonardo graduated from the University of Campania "Luigi Vanvitelli" in Italy, where he specialized in Gastroenterology and Digestive Endoscopy. Subsequently, he specialized in Pediatrics and Internal Medicine at the University of Modena and Reggio Emilia. Since April 1988, he has devoted his entire professional career to Modena, initially at the Sant'Agostino Hospital, then at the Policlinico, and later at the Baggiovara Civil Hospital since its opening. In 2017, Amedeo Lonardo obtained his qualification for National Scientific Qualification in Internal Medicine and Gastroenterology. His primary research focuses on the metabolic pathology of the liver, i.e., the “fatty liver”, which is an indicator and a cause of cardio-metabolic alterations such as diabetes, hypertension, and dyslipidemia. He extensively studies the various clinical manifestations, associations, and complications of fatty liver. He has been on the board of the scientific journal World Journal of Gastroenterology since 2018.

Prof. Giovanni Targher    
Honorary Editor-in-Chief of M&TOD    
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy.    
Giovanni Targher is an Associate Professor of Endocrinology and Diabetology at the University Medical School and Senior Consultant of Endocrinology at the Diabetes and Endocrinology Division, Hospital Trust, Verona, Italy. He received the MD Degree from the University of Verona in 1991 and has been a Board-Certified Specialist in Endocrinology and Diabetology at the University of Verona since 1996. He received several awards or prizes from the Italian Society of Diabetology, the Italian Association of Clinical Endocrinologists, the Italian Society for the Study of Atherosclerosis, and the American Association of Clinical Endocrinologists. He currently serves as an Editorial Board member of several reputed scientific journals. For over 15 years, his major research interest has been the cause and prevention of nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) using clinical epidemiology and health services translational approaches. He has authored over 600 peer-reviewed scientific articles and reviews, accumulating a citation count exceeding 40,000.

Prof. Christopher D. Byrne      
Honorary Editor-in-Chief of M&TOD      
Faculty of Medicine, University of Southampton, Southampton, UK.     
Christopher D. Byrne received training as a clinical scientist in the UK and the US, attending Cardiff, Cambridge, and Stanford Universities, and pursued a PhD studying liver lipid metabolism at Cambridge University. Following a post-doctoral fellowship at Stanford University and then a Medical Research Council (MRC) fellowship at Cambridge University, he assumed the Chair of Endocrinology & Metabolism at the University of Southampton in 1999 and served as the inaugural Director of the Welcome Trust Clinical Research Facility at Southampton. He is a clinical scientist conducting original research related to metabolic syndrome, obesity, and nonalcoholic fatty liver disease (NAFLD). Since 2008, he has been ranked ninth globally in NAFLD research and was honored with the ACCEA Silver Award in 2016. In 2021, he won Banting Memorial Lecture Award 2022. He was ranked World Expert and 5th in the world by Expertscape for research in NAFLD (2010-2022) in 2022.

The full list of "2023 Highly Cited Researchers" can be accessed here: https://clarivate.com/highly-cited-researchers/

Editor: Alani Luo      
Language Editor: Catherine Yang      
Production Editor: Kenny Wu      
Respectfully Submitted by the Editorial Office of Metabolism and Target Organ Damage